{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:05:51Z","timestamp":1791295551531,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T00:00:00Z","timestamp":1271894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T00:00:00Z","timestamp":1271894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/leu.2010.77","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T09:43:47Z","timestamp":1271929427000},"page":"1146-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms"],"prefix":"10.1038","volume":"24","author":[{"given":"A","family":"Pardanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T L","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R F","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,22]]},"reference":[{"key":"BFleu201077_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807\u20131812.","journal-title":"Science"},{"key":"BFleu201077_CR2","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765\u2013773.","journal-title":"N Engl J Med"},{"key":"BFleu201077_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/humu.20937","volume":"30","author":"FE Bleeker","year":"2009","unstructured":"Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP et al. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 2009; 30: 7\u201311.","journal-title":"Hum Mutat"},{"key":"BFleu201077_CR4","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/ijc.24647","volume":"125","author":"SW Park","year":"2009","unstructured":"Park SW, Chung NG, Han JY, Eom HS, Lee JY, Yoo NJ et al. Absence of IDH2 codon 172 mutation in common human cancers. Int J Cancer 2009; 125: 2485\u20132486.","journal-title":"Int J Cancer"},{"key":"BFleu201077_CR5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","volume":"361","author":"ER Mardis","year":"2009","unstructured":"Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058\u20131066.","journal-title":"N Engl J Med"},{"key":"BFleu201077_CR6","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1182\/blood-2009-11-253070","volume":"115","author":"WC Chou","year":"2010","unstructured":"Chou WC, Hou HA, Chen CY, Tang JL, Yao M, Tsay W et al. Distinct clinical and biological characteristics in adult acute myeloid leukemia bearing isocitrate dehydrogenase 1 (IDH1) mutation. Blood 2010; 115: 2749\u20132754.","journal-title":"Blood"},{"key":"BFleu201077_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010; 17: 225\u2013234.","journal-title":"Cancer Cell"},{"key":"BFleu201077_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMc0910063","volume":"362","author":"A Green","year":"2010","unstructured":"Green A, Beer P . Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms. N Engl J Med 2010; 362: 369\u2013370.","journal-title":"N Engl J Med"},{"key":"BFleu201077_CR9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937\u2013951.","journal-title":"Blood"},{"key":"BFleu201077_CR10","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","volume":"174","author":"T Watanabe","year":"2009","unstructured":"Watanabe T, Nobusawa S, Kleihues P, Ohgaki H . IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 2009; 174: 1149\u20131153.","journal-title":"Am J Pathol"},{"key":"BFleu201077_CR11","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.1158\/1078-0432.CCR-09-0715","volume":"15","author":"S Nobusawa","year":"2009","unstructured":"Nobusawa S, Watanabe T, Kleihues P, Ohgaki H . IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 2009; 15: 6002\u20136007.","journal-title":"Clin Cancer Res"},{"key":"BFleu201077_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hon.899","volume":"28","author":"GR Ruan","year":"2009","unstructured":"Ruan GR, Jiang B, Li LD, Niu JH, Li JL, Xie M et al. MPL W515L\/K mutations in 343 Chinese adults with JAK2V617F mutation-negative chronic myeloproliferative disorders detected by a newly developed RQ-PCR based on TaqMan MGB probes. Hematol Oncol 2009; 28: 33\u201339.","journal-title":"Hematol Oncol"},{"key":"BFleu201077_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/sj.leu.2405097","volume":"22","author":"A Tefferi","year":"2008","unstructured":"Tefferi A, Lasho TL, Huang J, Finke C, Mesa RA, Li CY et al. Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival. Leukemia 2008; 22: 756\u2013761.","journal-title":"Leukemia"},{"key":"BFleu201077_CR14","doi-asserted-by":"publisher","first-page":"33946","DOI":"10.1074\/jbc.M404298200","volume":"279","author":"X Xu","year":"2004","unstructured":"Xu X, Zhao J, Xu Z, Peng B, Huang Q, Arnold E et al. Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity. J Biol Chem 2004; 279: 33946\u201333957.","journal-title":"J Biol Chem"},{"key":"BFleu201077_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1126\/science.1170944","volume":"324","author":"S Zhao","year":"2009","unstructured":"Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009; 324: 261\u2013265.","journal-title":"Science"},{"key":"BFleu201077_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009; 462: 739\u2013744.","journal-title":"Nature"},{"key":"BFleu201077_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20092506","volume":"207","author":"S Gross","year":"2010","unstructured":"Gross S, Cairns RA, Minden MD, Driggers EM, Bittinger MA, Jang HG et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med 2010; 207: 339\u2013344.","journal-title":"J Exp Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201077","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T23:52:45Z","timestamp":1711410765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,22]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFleu201077"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.77","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,22]]},"assertion":[{"value":"10 February 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}